Enterprise Introduction
Sinopharm Zhijun(ShenZhen) Pharmaceutical. Co. Ltd was established in 1985, formerly known as Shenzhen Pharmaceutical Factory, has always been the key role in the cephalosporin manufacturing lineup of SINOPHARM group and the core manufacturing enterprise in Sinopharm Accord. Through 30 years of endeavor, Sinopharm Zhijun has grown up into a national high-tech enterprise which possessed a total of more than RMB1.2 billionm, 1.6bilion RMB annual turnovers 300 million RMB annual total profit and over RMB 150 million tax-paying. With approximately 1300 employees who are dedicated to the development of quality, efficiency, technology, Sinopharm Zhijun has ranked among Top100 pharmaceutical companies in China. Sinopharm Zhijun is mainly focusing on anti-infective products. Based on an international standardized R&D and production premise of 42,000 square kilometers,Sinopharm Zhijun owns 20 production lines within 5 workshops for cephalosporin. What’s more, both cephalosporin injectable and oral solid facilities have got the EU GMP approval. A series of market leading products have established by Sinopharm Zhijun with stringent quality control and management system and aggressive marketing network. Dalixin and Dalifen are the dominating products among the same category, which symbolize the Dali brand and Zhijun brand to the leading position of the marketplace. Meanwhile, the company is expanding the business in overseas markets and building strong reputation profile in global marketplace step by step. In future, Sinopharm Zhijun will integrate R&D and marketing and devote into technology innovation. With excellent quality and core competitive advantages, Sinopharm Zhijun aims to be pharmaceutical products and healthcare service provider in both domestic and international market with brand impact.

Enterprise honor